Skip to main content
OpenTrials
Completed

NCT Number: NCT01027312

Assessment of Ability Related to Vision

To determine the clinical usefulness of a refined third-generation instrument - The Assessment of Ability Related to Vision (AARV) in establishing the amount of disability, charting the detrimental effects of progressive disease and establishing the beneficial effects of treatment

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

This research study is designed to test the usefulness and repeatability of testing how much disability is caused by vision loss due to glaucoma. We are recruiting 100 patients with glaucoma and 20 healthy (have no eye disease) individuals to be enrolled in this study. The healthy study participants will be enrolled in order to describe how a healthy individual will perform on the test designed to assess one's performance when completing ten activities of daily living.

Clinical testing will be conducted by binocular and monocular visual fields, contrast sensitivity and visual acuity. The NEI-VFQ 15 Quality of Life Questionnaire will be used to measure patients perception of how well they are doing.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients 18 yrs of age and older
  • must understand and respond to spoken English and be fully literate.

Exclusion criteria

  • Patients with significant neurological problems (like Parkinson's disease), motor problems (like arthritis) or other significant illnesses that may prevent them from completing the testing involved in the study (like advanced heart failure).
  • Patients who have received training related to low vision.

Treatment and study plan

Primary outcomes

  1. the reproducibility of AARV, and its relationship to standard clinical tests

    Time frame: Day 1, 1 week, 6 months, 1 year

Secondary outcomes

  1. A better estimate of the reproducibility of standard clinical tests.

    Time frame: Day 1, 1 week, 6 months, 1 year

Sponsors and collaborators

Lead sponsor

Wills Eye

Other

Collaborators

  • Pfizer

Registry information

Official study title

Reproducibility and Clinical Usefulness of AARV (Assessment of Ability Related to Vision)

Acronym: AARV

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Dec 7, 2009
Registry last updated
Nov 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.